| Income Statement | 2026-04-30 | |||
|---|---|---|---|---|
| Revenue, net | 3,025,538 | |||
| Cost of revenue | 2,114,949 | |||
| Gross profit | 910,589 | |||
| Sales and distribution expenses | 2,900 | |||
| Personnel and benefit costs | 170,293 | |||
| General and administrative expenses | 733,795 | |||
| Total operating expenses | 906,988 | |||
| Income from operations | 3,601 | |||
| Interest expense | 0 | |||
| Sundry income | 2,980 | |||
| Total other income (expenses), net | 2,980 | |||
| Income before income tax | 6,581 | |||
| Income tax expense | 43,885 | |||
| Net income (loss) | -37,304 | |||
| Basic EPS | -0.004 | |||
| Basic Average Shares | 8,337,454 | |||
VitaNova Life Sciences Corp (VNOV)
VitaNova Life Sciences Corp (VNOV)